Management of Diabetes Mellitus in Normal Renal Function, Renal Dysfunction and Renal Transplant Recipients, Focusing on Glucagon-Like Peptide-1 Agonist: A Review Based upon Current Evidence

Diabetes Mellitus (DM) is a leading cause of both Cardiovascular Disease (CVD) and End-stage Renal Disease (ESRD). After 2008, there has been much evidence presented, and recently the guidelines for sugar control have changed to focus on being more disease orientated. GLP-1 Receptor Agonists (GLP-1R...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Shang-Feng, Chen, Cheng-Hsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651241/
https://www.ncbi.nlm.nih.gov/pubmed/31261624
http://dx.doi.org/10.3390/ijms20133152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651241/
https://www.ncbi.nlm.nih.gov/pubmed/31261624
http://dx.doi.org/10.3390/ijms20133152

Ejemplares similares